11 July 2023
11 July 2023
The company plans to commercially launch the new device in the fourth quarter of this year.
The new facility will also help deliver and repair endoscopic solutions for medical institutions in the country.
The arrival of the fourth dimension of printing.
Xtant Medical ends private placement fund with over 20 million common stock shares sold.
The system will come with Hizentra 10 mL prefilled syringes, approved by the FDA in April 2023.
The device helps to strengthen the quadriceps muscles by leveraging neuromuscular stimulation technology.
The new Apollo4 Lite and Apollo4 Blue Lite System-on-Chips are suitable for remote healthcare monitoring products.
The clinical trial will evaluate the use of the system for the treatment of COPD.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
